CLDX Operating Cash Flow Growth

Celldex Therapeutics Inc · Operating Cash Flow Growth

CLDX logo

CLDX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-30.46%
CLDX Quarterly Cash from Operations YoY % (-105.56% → -30.46%)
High-resolution chart · PNG

CLDX operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-30.4624%
-20.6283%
-96.8839%
12.1239%
-50.0494%
-33.796%
0.1752%
-191.3547%
-7.8357%
-42.2451%
-49.4945%
46.0303%
-22.2622%
-16.4466%
-49.8451%
-114.9524%
-86.4543%
-35.6669%
-178.6989%
-38.0322%
-6.309%
-49.3311%
52.6273%
-6.4722%
-1.6301%
8.4864%
28.7103%
22.5744%
36.522%
52.7764%
20.9569%
40.9384%
16.3179%
20.532%
4.069%
-1.6948%
38.5545%
-1.0315%
-48.0466%
13.803%
-36.6206%
-7.0975%
38.1246%
-4.5089%
-18.7284%
-2.24%
-48.5191%
-52.3548%
-15.4945%
-85.3198%
-12.2392%
-59.4846%
-50.9992%
-26.9092%
-42.2199%
-35.7985%
-27.6989%
-52.8994%
-55.7772%
-4.0945%
3.2041%
-27.7233%
44.5264%
-40.6613%
-21.3618%
-25.0457%
-937.4105%
38.6996%
-126.3352%
-28.8672%
132.1038%
-97.3957%
779.9836%
31.3051%
-104.4005%
-17.7378%
-4.7574%
-116.9047%
-195.1405%
9.1848%
-2,137.0015%
1,016.8035%
158.6602%
-41.2508%
112.686%
-87.6162%
-7.6778%
-10.6876%
38.1185%
29.9399%
-254.1689%
47.2745%
48.525%
43.1051%
83.0388%
10.2818%
-19.0083%
-2.6492%
-1,803.2033%
-128.6947%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.